APA-Zitierstil (7. Ausg.)

National Academies (U.S.) Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II. (2011). A risk-characterization framework for decision-making at the Food and Drug Administration. National Academies Press.

Chicago-Zitierstil (17. Ausg.)

National Academies (U.S.) Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II. A Risk-characterization Framework for Decision-making at the Food and Drug Administration. Washington D.C: National Academies Press, 2011.

MLA-Zitierstil (9. Ausg.)

National Academies (U.S.) Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II. A Risk-characterization Framework for Decision-making at the Food and Drug Administration. National Academies Press, 2011.